Biogaia AB (BIOGb.ST)

BIOGb.ST on Stockholm Stock Exchange

176.00SEK
23 Dec 2014
Price Change (% chg)

-2.00kr (-1.12%)
Prev Close
178.00kr
Open
179.00kr
Day's High
180.00kr
Day's Low
176.00kr
Volume
11,000
Avg. Vol
13,946
52-wk High
254.00kr
52-wk Low
151.00kr

BIOGb.ST

Chart for BIOGb.ST

About

Biogaia AB is a Sweden-based company engaged in the development and sell of probiotic products, primarily based on the Lactobacillus reuteri bacteria. The Company’s activities are divided into three segments: Finished consumer products, which distributes tablets, drops, Oral Rehydration Solutions (ORSs), and oral health... (more)

Overall

Beta: 0.83
Market Cap (Mil.): kr2,909.33
Shares Outstanding (Mil.): 16.53
Dividend: 3.35
Yield (%): 3.98

Financials

  BIOGb.ST Industry Sector
P/E (TTM): 20.89 23.58 34.01
EPS (TTM): 8.42 -- --
ROI: 44.47 11.90 64.46
ROE: 46.41 15.43 72.77
Search Stocks

BRIEF-Biogaia invests in research firm MetaboGen

BioGaia has decided to invest SEK 12 million in MetaboGen AB, Gothenburg, Sweden.

01 Dec 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks